Published in Vaccine Weekly, September 9th, 1996
The intranasal influenza vaccine is tested in a randomized double-blind placebo-controlled study in more than 900 children aged 15 through 71 months of age in a multi-center trial in collaboration with the U.S. National Institute of Allergy and Infectious Disease (NIAID), of the U.S. National Institutes of Health (NIH), with whom Aviron has entered into a Collaborative Research and Development Agreement (CRADA) in...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.